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Tokyo, Japan.Introduction
It is well established that type 1 Brugada syndrome (BrS)
is associated with ventricular ﬁbrillation (VF).1 Recently,
Morita et al2 suggested in an experimental model that
radiofrequency catheter ablation applied to the right ven-
tricular (RV) epicardium might be more effective than
radiofrequency ablation applied to the endocardium in order
to eliminate ventricular tachycardia in patients with BrS. In
addition, Nademanee et al3 reported that the likely under-
lying electrophysiological mechanism in patients with BrS
was a delayed depolarization involving the anterior epicar-
dial region of the right ventricular outﬂow tract (RVOT).
They also reported that catheter ablation over this abnormal
area resulted in normalization of the electrocardiographic
(ECG) characteristics of BrS and prevented ventricular
tachyarrhythmias. To our knowledge, we describe here the
ﬁrst case report demonstrating extensive epicardial bipolar
voltage abnormality in a patient with BrS and coexistent
J waves that was modiﬁed by ablation with good VF control.Case report
We describe unique mapping and ablation results obtained
from a 38-year-old man with a ﬁxed type 1 Brugada ECG
pattern (Figure 1A) with clinical diagnosis of BrS because of
recurrent VF episodes and multiple appropriate shocks from
his implantable cardioverter-deﬁbrillator. Extensive inves-
tigations including echocardiography, cardiac magnetic res-
onance imaging, and an endocardial bipolar voltage mapKEYWORDS Brugada syndrome; J wave; Epicardium; Ablation; Ventricular
ﬁbrillation
ABBREVIATIONS BrS ¼ Brugada syndrome; ECG ¼ electrocardiographic;
RV ¼ right ventricle/ventricular; RVOT ¼ right ventricular outflow tract;
VF ¼ ventricular fibrillation (Heart Rhythm Case Reports 2015;1:82–84)
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(http://creativecommons.org/licenses/by-nc-nd/4.0/).were essentially normal. However, an endocardial unipolar
voltage map detected an abnormal low-voltage area in the
perivalvular RV (Figure 2), and furthermore, a detailed
epicardial bipolar voltage map identiﬁed abnormal low-
voltage areas with highly fractionated electrograms located
in the anterior RVOT and inferior RV epicardially (Figure 3).
Epicardial ablation procedures were performed with the goal
of eliminating abnormal electrograms. The ablation power
setting was 20–25 W, with a temperature limited at 411C by
using an open-irrigated ablation catheter for a duration of
20–30 seconds at each target site. The amplitude of the
negative T waves recorded in leads V1 and V2 was attenuated
after epicardial ablation procedures targeting the anterior
RVOT scar (Figure 1B). Furthermore, J-wave amplitudes
were notably smaller in leads II and aVF, while S waves
became more prominent after additional epicardial ablation
procedures targeting the inferior aspect of the RV
(Figure 1C). The patient has been free from any VF
recurrence at 20-month clinic follow-up.
Discussion
This clinical case demonstrated the effect of epicardial
ablation on coexistent J-wave morphologies recorded by
the inferior leads in a patient with clinical diagnosis of BrS.
Nademanee et al3 reported several important ﬁndings regard-
ing BrS. First, abnormal delayed depolarization was
observed in the anterior epicardial aspect of the RVOT.
Second, this aforementioned epicardial region was likely to
be implicated as an arrhythmogenic focus underlying BrS.
Third, catheter ablation targeting this abnormal epicardial
region of the RVOT resulted in normalization of the Brugada
ECG pattern. Finally, radiofrequency ablation delivery in
this epicardial region may prevent ventricular tachyarrhyth-
mia recurrence in patients with frequent recurrent VF
episodes.
Several similar features were observed in our patient,
namely, a typical type 1 Brugada ECG pattern, abnormal
long-duration highly fractionated late potentials recorded
exclusively within abnormal regions in the epicardium, andpen access article under the CC BY-NC-ND license
http://dx.doi.org/10.1016/j.hrcr.2015.01.012
Figure 1 Electrocardiograms before and after stepwise epicardial ablation
procedures: (A) before ablation, (B) after right ventricular outﬂow tract
epicardial ablation, and (C) after inferior right ventricular epicardial ablation.
Figure 2 Endocardial unipolar voltage map of the right ventricle using a
voltage range from 0 to 5.5 mV is illustrated in the right anterior oblique
(RAO) orientation.
KEY TEACHING POINTS
 This is the ﬁrst case report illustrating extensive
epicardial bipolar voltage abnormality in a patient
with clinical diagnosis of Brugada syndrome and
coexistent J waves that was modiﬁed by ablation
and good medium-term ablation outcome.
 An endocardial unipolar voltage map detected an
abnormal low-voltage area in the perivalvular right
ventricle, and furthermore, a detailed epicardial
bipolar voltage map identiﬁed abnormal low-
voltage areas with highly fractionated
electrograms located in the anterior right
ventricular outﬂow tract and inferior right
ventricle epicardially.
 Our ﬁndings of abnormal endocardial and
epicardial voltages on detailed electroanatomical
mapping may be further evidence that most
patients with Brugada syndrome may not have a
“pure” ion channel disease but that the clinical
phenotype corresponding to the Brugada
electrocardiographic pattern involves different
degrees of pathological myocardial involvement by
a (yet undeﬁned) cardiomyopathic process.
83Maeda et al Epicardial Ablation of Brugada Syndrome With J Wavesmodiﬁcation of the type 1 Brugada ECG pattern after
ablation of the epicardial site in the anterior RVOT.
Importantly, our case also differed as highlighted by the
presence of abnormal epicardial potential localizations
based on the pattern of low bipolar epicardial voltages that
were not limited to the RVOT. Intriguingly, these abnormal
voltages also extended to involve the inferior RV epicar-
dially, while the endocardial bipolar voltages were normal.
Furthermore, the amplitude of the negative T waves detected
in leads V1 and V2 was attenuated, the J waves were
evidently smaller in leads II and aVF, and S waves became
more prominent after epicardial ablation procedures target-
ing these regions.
It has been reported that the presence of J waves in
multiple leads may indicate a highly arrhythmogenic sub-
strate in patients with BrS.4 On the basis of the epicardial
ﬁndings in this case, coexistent J waves in BrS may indicate
more extensive and heterogeneous epicardial abnormalities
associated with an increased susceptibility to ventricular
arrhythmias.
In addition, Catalano et al5 reported the presence of mild
structural changes in the RV that were detectable with
magnetic resonance imaging. Similarly, Frustaci et al6
reported evidence of concealed cardiomyopathic substrates
at endomyocardial biopsy in patients with clinical phenotype
of BrS. Our ﬁndings of abnormal endocardial and epicardial
voltages on detailed electroanatomical mapping may befurther evidence that most patients with BrS may not have
a “pure” ion channel disease but that the clinical phenotype
corresponding to the Brugada ECG pattern involves different
degrees of pathological myocardial involvement by a (yet
undeﬁned) cardiomyopathic process.
To our knowledge, this is the ﬁrst case report illustrating
extensive epicardial bipolar voltage abnormality in a patient
with clinical diagnosis of BrS and coexistent J waves that
was modiﬁed by ablation and good medium-term ablation
outcome.
Figure 3 Epciardial bipolar voltage map of the right ventricle (RV) is shown using a voltage range from 0.5 to 1.0 mV. The epicardial RV voltage map
identiﬁed a low-voltage area in the inferior RV. Fractionated and late potentials were tagged with white, clustering in the RVOT and inferior RV. RFA
procedures were applied to eliminate abnormal electrogram areas with good clinical efﬁcacy. RAO ¼ right anterior oblique; RF ¼ radiofrequency; RFA ¼
radiofrequency ablation.
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